Results 171 to 180 of about 33,286 (224)
Seroprevalence of Marburg virus: A modeling study in endemic area. [PDF]
Kleebayoon A, Wiwanitkit V.
europepmc +1 more source
In silico drug repurposing of potential antiviral inhibitors targeting methyltransferase (2'-O-MTase) domain of Marburg virus. [PDF]
De A, Subramanian S, Nayak P, Pal K.
europepmc +1 more source
Marburg virus vaccine in Rwanda: A necessity for the control and prevention of future epidemics. [PDF]
Tague C +9 more
europepmc +1 more source
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. [PDF]
Subramani C +10 more
europepmc +1 more source
Marburg virus disease in Rwanda: an observational study of the first 10 days of outbreak response, clinical interventions, and outcomes. [PDF]
Absolomon G +14 more
europepmc +1 more source
A call for structured mental health interventions in epidemic response: lessons from the Marburg virus outbreak in Rwanda. [PDF]
Gashugi Y +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
MARBURG-VIRUS DISEASE IN KENYA
The Lancet, 1982Abstract The third known outbreak of Marburg-virus disease occurred in Kenya in 1980. The index patient acquired infection in western Kenya, and a doctor in close contact with the patient terminally during a massive haematemesis developed infection in Nairobi. There was no further evidence of nosocomial transmission.
D H, Smith +8 more
openaire +4 more sources

